JNJ executive exercises 15,571 stock options

Johnson & Johnson executive Timothy Schmid, EVP and Worldwide Chair of MedTech, reported routine equity transactions on February 6, 2026.

Rhea-AI Filing Summary

Johnson & Johnson executive Timothy Schmid, EVP and Worldwide Chair of MedTech, reported routine equity transactions on February 6, 2026. He exercised 15,571 employee stock options at $101.87 per share through an automatic exercise immediately before expiration, receiving the same number of common shares.

To cover the option exercise price and related taxes, 10,335 common shares were withheld at a value of $239.99 per share, leaving 22,125 common shares held directly after the transactions. He also reports indirect ownership of 745 shares through a 401(k) plan and 46 shares through an ESOP under the Johnson & Johnson Savings Plan.

Insider Trade Summary

15,571 shares exercised/converted

Exercise 5 txns

Insider Schmid Timothy

Role EVP, WW Chair, MedTech

Type	Security	Shares	Price	Value
Exercise	Employee Stock Options (Right to Buy)	15,571	$101.87	$1.59M
Exercise	Common Stock	15,571	$101.87	$1.59M
Exercise Price or Tax Liability	Common Stock	10,335	$239.99	$2.48M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 contracts (Direct); Common Stock — 22,125 shares (Direct); Common Stock — 745 shares (Indirect, By 401k); Common Stock — 46 shares (Indirect, By ESOP)

Footnotes (4)

1. F1. Reflects the auto-exercise of options immediately prior to their expiration.
2. F2. Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.
3. F3. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
4. F4. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Johnson & Johnson (JNJ) executive Timothy Schmid report in this Form 4?

Timothy Schmid reported an automatic exercise of 15,571 stock options at $101.87 per share and related share withholding for taxes and exercise price, resulting in 22,125 common shares held directly, plus additional indirect retirement-plan holdings.

How many Johnson & Johnson (JNJ) options did Timothy Schmid exercise?

He exercised 15,571 employee stock options on February 6, 2026 at an exercise price of $101.87 per share. The filing notes this was an auto-exercise immediately before expiration, converting these options into an equal number of Johnson & Johnson common shares.

How many Johnson & Johnson (JNJ) shares were withheld for taxes and exercise costs?

The filing shows 10,335 common shares were withheld at a value of $239.99 per share. According to the footnotes, these shares covered the option exercise price and associated taxes tied to the 15,571 stock option exercise.

What is Timothy Schmid’s direct Johnson & Johnson (JNJ) share ownership after the transactions?

After the reported transactions, Timothy Schmid directly holds 22,125 Johnson & Johnson common shares. This figure reflects the 15,571 shares received from the option exercise, net of the 10,335 shares withheld to cover the exercise price and related tax obligations.

Does Timothy Schmid report any indirect Johnson & Johnson (JNJ) share holdings?

Yes. He reports 745 shares held indirectly through a 401(k) plan and 46 shares held through an ESOP, both under the Johnson & Johnson Savings Plan, based on the plan’s most recent reporting date of January 31, 2026.

Was the Johnson & Johnson (JNJ) option exercise discretionary or automatic?

The filing states the transaction reflects the auto-exercise of options immediately before their expiration. This indicates the 15,571 options were exercised automatically under their terms, rather than through a separate discretionary trading decision on that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 09:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schmid Timothy

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, WW Chair, MedTech

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		15,571(1)	A	$101.87	32,460	D
Common Stock	02/06/2026		F		10,335(2)	D	$239.99	22,125	D
Common Stock								745(3)	I	By 401k
Common Stock								46(4)	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$101.87	02/06/2026		M			15,571	02/09/2019	02/08/2026(1)	Common Stock	15,571	$101.87	0	D

Explanation of Responses:

1. Reflects the auto-exercise of options immediately prior to their expiration.

2. Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

3. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

4. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.